Tag: treatments for neuroendocrine tumors

Luncheon with the Experts, l to r, Drs. Michail Shafir, Edward Wolin, Jerome Zacks, October 2018

October Luncheon with the Experts in White Plains, NY for the Neuroendocrine Tumor Community

August 14, 2018

The Big Apple NETs support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and 3 medical experts for Lunch with the Experts on Sunday, October 14, 2018 at 12:30 pm at the Westchester Hills Golf Club, 401 Ridgeway …

READ MORE
FDA logo

Breaking News: US FDA Approves Lanreotide for Gastroenteropancreatic Neuroendocrine Tumors

December 16, 2014

December 16, 2014: The US Food and Drug Administration (FDA) today approved “lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic

READ MORE
Josh Mailman_5

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting

April 25, 2014

Josh Mailman, President of the NorCal CarciNET Community  and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…

READ MORE
Ottawa, Chateau Laurier, Conference Center

2012 CNETS Canada Carcinoid and Neuroendocrine Conference Joins Medical Professionals, Patients & Caregivers

February 5, 2012

Carcinoid cancer and neuroendocrine tumor specialists from around the world, fascinating presentations on all aspects of these rare diseases, the opportunity to meet fellow carcinoid and neuroendocrine tumor (NETs)  patients and caregivers from…

READ MORE
Emily Bergsland, MD

California Carcinoid and Neuroendocrine Tumor Conference Scheduled for January

November 20, 2011

Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California.  The latest developments in NET cancers, including clinical trials, …

READ MORE
Siemens’ Biograph mMR system

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

June 12, 2011

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid

READ MORE